EGFR and cancer: Surprisingly, the OPLS-DA performed for identified mutant proteins demonstrated profound differences in distance among the different EGFR mutation groups, L858R, Ex19del, and no L858R/Ex19del, suggesting that cancer cells harboring L858R or Ex19del emerge from cellular origins differently from L858R/Ex19del-negative cells (Figure 2B).